Table 1 Patient characteristics
Total no. of patients | 108 |
|---|---|
Sex: male/female | 63/45 |
Total colonoscopy | 199 |
Number of colonoscopies | |
 1 | 58 |
 2 | 30 |
 ≧3 | 20 |
Age during colonoscopy: median (range) | 44 (12–72) years |
Disease duration during colonoscopy: median (range) | 9 (0–38) years |
Montreal classification (%) | |
 E1/E2/E3 | 38 (19.1)/47 (23.6)/114 (57.3) |
Clinical score at colonoscopy: median (range) | |
 CAI | 0 (0–4) |
Mayo endoscopic score: median (range) | 1 (0–3) |
Blood examination: median (range) | |
 CRP | 0.04 (0.02–1.09) |
 SAA | 5.5 (5.5–90.1) |
Therapies (%) | |
 Mesalamine | 178 (89.4) |
 Corticosteroids | 18 (9.0) |
 Immunomodulators | 71 (35.7) |
 Biologics | 24 (12.1) |